Skip to main content

EW

Stock

EW

Stock
Health Care
Medical Devices

Performance overview

EW Price
Price Chart

Forward-looking statistics

Beta
1.00
Risk
35.89%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.

Company info

SectorHealth Care
IndustryMedical Devices
Employees16K
Market cap$53.1B

Fundamentals

Enterprise value$42.7B
Revenue$5.5B
Revenue per employee—
Profit margin75.71%
Debt to equity6.86

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$2.42
Dividend per share—
Revenue per share$9.30
Avg trading volume (30 day)$307M
Avg trading volume (10 day)$322M
Put-call ratio—

Macro factor sensitivity

Growth+2.9
Credit+1.5
Liquidity-1.1
Inflation-0.7
Commodities+1.5
Interest Rates-1.3

Valuation

Dividend yield0.00%
PEG Ratio31.34
Price to sales8.16
P/E Ratio31.34
Enterprise Value to Revenue7.74
Price to book4.44

Upcoming events

Next earnings dayApril 24, 2025
Next dividend day—
Ex. dividend day—

News

Trump announces significant 30% tariffs against Mexico, EU to begin next month

President Trump imposes new 30% tariffs on Mexican and EU imports effective August 1, warning that any retaliatory measures will be matched and added to the base rate

Fox Business (July 12, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free